Correction: ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma

Affiliations

• ¹ Division of Cancer, Department of Surgery and Cancer, Imperial College, London, UK.
• ² MRC Toxicology Unit, University of Cambridge, Cambridge, UK.
• ³ Gemini Biosciences, Liverpool, UK.
• ⁴ Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
• ⁵ Division of Cancer, Department of Surgery and Cancer, Imperial College, London, UK. m.seckl@imperial.ac.uk.
• ⁶ Division of Cancer, Department of Surgery and Cancer, Imperial College, London, UK. o.pardo@imperial.ac.uk.